Scorpion Envenomation — Comprehensive Research Report

1. Disease Information

Overview. Scorpion envenomation is the clinical syndrome produced by injection of venom through the telson (stinger) of a scorpion, ranging from a trivial local sting to a life-threatening toxicological emergency dominated by autonomic "storm," neuromuscular hyperexcitability, and cardiopulmonary collapse. Of more than 2,900 described scorpion species, roughly 100 (nearly all in family Buthidae) are of medical significance (Medscape/eMedicine overview; PMC8158070 "Neurological and Systemic Manifestations of Severe Scorpion Envenomation"). It is classified by WHO among the neglected tropical diseases of high public-health relevance in endemic regions (PMC12170520, "Scorpionism: a neglected tropical disease with global public health implications," 2025).

Key identifiers. - MONDO: MONDO:0018755 (scorpion envenomation; "has cause: scorpion sting") - ICD-10-CM: T63.2 (Toxic effect of venom of scorpion), with subcodes T63.2X1– (accidental), T63.2X3– (assault), T63.2X4– (undetermined) - MeSH: "Scorpion Stings" (D012620) - Note: this is an injury/toxicological entry rather than a classical Mendelian or complex genetic disease — OMIM/Orphanet do not carry a disease record for it (consistent with the "Injury" category assigned to this stub).

Synonyms/alternative names: scorpionism, scorpion sting, scorpion stinging, scorpion poisoning, scorpion toxicosis (veterinary literature).

Evidence basis. Information is derived overwhelmingly from aggregated clinical/epidemiologic case series, hospital cohorts, and national poison-control/registry data (Mexico, Brazil, Iran, Tunisia, Morocco, India) rather than individual-patient EHR mining, supplemented by controlled clinical trials of antivenom and toxin-mechanism studies in animal/cell models.

Sources: Scorpion Envenomation – Medscape · Neurological and Systemic Manifestations of Severe Scorpion Envenomation – PMC8158070 · Scorpionism: a neglected tropical disease – PMC12170520 · scorpion envenomation – Wikidata Q55788313 · ICD-10 T63.2X1A – icd10data.com

2. Etiology

Disease causal factor: direct envenomation — injection of a complex peptide/protein venom through the scorpion telson. This is a mechanistic/toxicological (not genetic) etiology; there is no host causal gene. All "risk factors" below are risk factors for exposure or for severity of envenomation, not for genetic disease susceptibility per se.

Genetic risk/modifier factors (host side): None established as disease-causing loci. The closest analogues in the literature are (a) age-dependent physiologic vulnerability (smaller body mass, immature autonomic/cardiovascular reserve in children) rather than a genotype, and (b) individual "sensitivity to venom" invoked qualitatively by Ministry of Health severity models without a defined genetic marker (PMC10615126, "Moderate or severe scorpion sting: identification of risk factors").

Environmental/exposure risk factors: - Geography — seven historically recognized high-risk regions: North Saharan Africa, Sahelian Africa, southern Africa, Near/Middle East, South India, Mexico, and northern South America/Amazon basin east of the Andes, covering an estimated 2.3 billion people at risk (Chippaux & Goyffon 2008, PMID:18579104, Acta Tropica 107:71-79). - Occupation — farming, agricultural labor, firewood collection, animal husbandry (handling ducks/hens), and rural residence. - Housing quality — thatched roofs, cracks/crevices in walls and floors that harbor scorpions; sleeping on the floor without a bed net. - Age — children under 15, and especially under 5–10 years, are disproportionately at risk of severe/fatal envenomation because of lower body mass amplifying effective venom dose per kg (multiple sources below). - Sting location — stings on the torso, head, or neck (closer to central circulation) predict faster systemic absorption and greater severity than distal-limb stings. - Time-to-treatment — delay >3 hours between sting and antivenom/hospital care is an independent severity predictor. - Climate/behavior — scorpion activity (and sting incidence) rises with warm-season nocturnal foraging.

Protective factors (environmental): footwear use, bed nets suspended below thatched roofs, sealing of household cracks/crevices, shaking out shoes/bedding before use, improved rural healthcare access enabling rapid antivenom administration, and community education/awareness campaigns.

Gene–environment interactions: not characterized in the literature as a formal GxE model; the closest is pharmacogenomic variability in individual antivenom/catecholamine response, which remains unstudied at a population-genetic level.

Sources: Epidemiology of scorpionism: a global appraisal – PMID:18579104 · Scorpionism at the human–environment interface – PMC13006650 · Moderate or severe scorpion sting: risk factors – PMC10615126 · DHMOSH UN Guidance for Prevention/Management of Scorpion Stings

3. Phenotypes

Local phenotypes (signs)

• Local pain/paresthesia at sting site — nearly universal, immediate, often severe and out of proportion to visible findings for buthid stings (HP:0012531 Pain / HP:0040218 Paresthesia). Onset: immediate. Frequency: ~99–100% for most species.
• Erythema, edema, tenderness (HP:0010783 Erythema) — mild local envenomation category, estimated ~68.6% of cases.
• Skin necrosis / bullae / ulceration — characteristic of cytotoxic species (Hemiscorpius lepturus), classically delayed and initially painless, evolving over days (HP:0031297 Skin ulcer). PMID:9679690 "Cutaneous manifestations of the Hemiscorpius lepturus sting."

Systemic/autonomic phenotypes

• Autonomic "storm" — mixed sympathetic and parasympathetic hyperactivity: tachycardia, hypertension, diaphoresis, hypersalivation, lacrimation, vomiting (cholinergic "SLUDGE" pattern) followed often by a later parasympathetic/hypotensive phase.
• Sympathetic predominance: tachycardia (HP:0001649), hypertension (HP:0000822), hyperthermia (HP:0001945), pulmonary edema (HP:0100598).
• Parasympathetic predominance: bradycardia (HP:0001662), hypotension (HP:0002615), sialorrhea/hypersalivation (HP:0002307), lacrimation, priapism (HP:0030731) — reported as a Grade II severity feature in children, pathogenically linked to acetylcholine-driven parasympathetic activation.
• Cardiotoxicity — arrhythmia, myocarditis, cardiogenic shock, congestive heart failure; onset can be within 2 hours of the sting. Reported mortality in confirmed scorpion myocarditis ≈7.3% (PLOS NTD systematic review, PMID:37018229).
• Pulmonary edema/respiratory failure — leading proximate cause of death; occurs with or without hemoptysis in 7–32% of respiratory cases; mechanism combines direct toxin-induced increased pulmonary vascular permeability with catecholamine-driven afterload/hypoxia.
• Neuromuscular hyperexcitability — fasciculations, tremor, opsoclonus/roving eye movements, trismus, dysarthria, cranial-nerve hyperactivity (HP:0001336 Myoclonus, HP:0002378 Fasciculations).
• Gastrointestinal — nausea, vomiting, abdominal pain, hypersalivation, and acute pancreatitis — hyperamylasemia in ~80% of a case series, elevated immunoreactive cationic trypsin in 93% of pediatric cases after Leiurus quinquestriatus stings (PMID:2028471).
• Endocrine/metabolic — stress hyperglycemia mediated by catecholamine/counter-regulatory hormone release, correlating with severity (recent 2025/2026 cohort, PMC12974955).
• Hematologic/renal (cytotoxic species, e.g., Hemiscorpius lepturus) — intravascular hemolysis, disseminated intravascular coagulation, acquired ADAMTS13 deficiency, hemolytic-uremic syndrome, acute kidney injury (PMID:23893367; PMC2813541; PMC11872030).
• Neurological complications (rare) — ischemic and hemorrhagic stroke, seizures, altered consciousness/coma (systematic review, PMC11403367).
• Local mechanical/traumatic sequelae — massive tissue defect reconstruction case reports for severe cytotoxic necrosis.

Phenotype characteristics

• Onset: typically minutes (local pain, autonomic symptoms); systemic/cardiopulmonary complications generally manifest within 1–6 hours, occasionally up to 24 hours.
• Severity/frequency by grade (commonly used 3–4 tier systems):
• Mild (Grade I): local pain ± paresthesia only — most common (~68.6% in one classification).
• Moderate (Grade II/III): ascending local signs, mild systemic signs, sweating, vomiting, tachycardia/tachypnea, hypertension, cranial-nerve involvement, twitching (~26.8%).
• Severe (Grade IV): profuse vomiting/sweating/salivation, seizures, coma, bradycardia, heart failure, severe pulmonary edema, shock — life-threatening.
• Progression: typically rapid (hours) rather than chronic; most survivors resolve within 24–48 hours with or without antivenom.
• Quality of life: acute, self-limited in the majority; severe cases can leave residual organ dysfunction (renal, cardiac) or, rarely, neurological deficits after stroke. Formal EQ-5D/SF-36 data specific to scorpion envenomation are not established in the literature reviewed.

Sources: Scorpion Envenomation Clinical Presentation – Medscape · Classification of clinical consequences of scorpion stings: consensus development · Neurological and Systemic Manifestations – PMC8158070 · Scorpion envenomation-associated myocarditis: systematic review – PMID:37018229 · Acute pancreatitis following Leiurus quinquestriatus envenomation – PMID:2028471 · Predictive value of admission blood glucose – PMC12974955 · Stroke as a rare complication of scorpion stings – PMC11403367 · ADAMTS13 deficiency after hemolysis – PMID:23893367 · Cutaneous manifestations of Hemiscorpius lepturus sting – PMID:9679690 · Scorpion Envenomation with Delayed Ischemic Priapism – AJTMH

4. Genetic/Molecular Information

Scorpion envenomation has no human causal gene — it is toxin-mediated, not a Mendelian disease. The relevant "genetic/molecular" content is the venom toxin side:

Venom toxin classes (the causal molecular agents): - Long-chain neurotoxins acting on voltage-gated Na⁺ channels (Nav): - α-NaTx (α-scorpion toxins, receptor site 3): bind the voltage-sensing domain IV (VSD4) of Nav channels and inhibit fast inactivation, prolonging Na⁺ current and depolarization. Structural work (cryo-EM, 3.5 Å) resolved a eukaryotic Nav channel in complex with the lethal α-toxin AaH2, showing it wedges into VSD4 and traps a deactivated gating-charge state ("Structural basis of α-scorpion toxin action on Nav channels," Science, DOI:10.1126/science.aav8573; PNAS PMID for site mapping: PMC3696675 "Modular Organization of α-Toxins"). - β-NaTx (β-scorpion toxins, receptor site 4): bind the S3b–S4 voltage-sensor paddle of domain II and shift voltage-dependence of activation to more hyperpolarized potentials, lowering the threshold for channel opening and causing repetitive/spontaneous firing (Rockefeller J Gen Physiol review of excitatory/depressant β-toxin modes). - Net physiological effect: massive, uncontrolled presynaptic neurotransmitter release (acetylcholine at parasympathetic terminals; norepinephrine/epinephrine at sympathetic terminals and adrenal medulla), producing the autonomic storm. - K⁺ channel toxins (KTx, α/β/γ/κ families): block Kv channels, further prolonging depolarization and neurotransmitter release; e.g., α-KTx4.9 from Tityus fasciolatus. - Bradykinin-potentiating peptides (BPPs) and natriuretic-like/hypotensin peptides (e.g., Tityus serrulatus Hypotensins, TsHpt) — contribute to vascular tone changes. - Enzymes: hyaluronidase (spreading factor), metalloproteinases, phospholipases. - Cytolytic/hemolytic toxins (notably Hemiscorpius lepturus): lysophospholipase D and related lytic enzymes causing cell-membrane lysis, hemolysis, and tissue necrosis — mechanistically distinct from the neurotoxic Buthidae venoms.

Nomenclature note for dismech curation: because there is no host causal gene, this section is best modeled via CHEBI (venom peptide/small-molecule mediators — e.g., acetylcholine CHEBI:15355, epinephrine CHEBI:33568, norepinephrine CHEBI:33569, prostaglandin E2 CHEBI:15551) and GO molecular function/biological process terms rather than HGNC gene bindings. The Nav1.x / Kv channel targets in the human host can be annotated with HGNC gene symbols where the specific isoform is documented (e.g., SCN9A/Nav1.7 hgnc:10598, SCN4A/Nav1.4 hgnc:10593) — the referenced study "CeII8/CeII9" toxins are isoform-selective for Nav1.7 vs Nav1.4 (PMID:20600228).

Allele frequency / somatic-germline / ACMG classification: not applicable — this is not a variant-based disease.

Modifier genes: none established; host channel isoform expression pattern (which Nav/Kv subtypes are expressed at a given synapse) determines tissue-specific toxin effect but is not itself a "modifier gene" in the ACMG sense.

Epigenetics/chromosomal abnormalities: not applicable.

Sources: Structural basis of α-scorpion toxin action on Nav channels – Science · Modular Organization of α-Toxins – PMC3696675 · Scorpion β-toxin interference with NaV channel voltage sensor – J Gen Physiol · Mapping the receptor site for α-scorpion toxins – PNAS · CeII8/CeII9 Nav1.7/Nav1.4-selective toxins – PMID:20600228 · Novel components of Tityus serrulatus venom – transcriptomic approach · Tityus serrulatus Hypotensins · Purification of neurotoxic peptides from Hemiscorpius lepturus – PMC7211352

5. Environmental Information

Environmental factor = the disease trigger itself: scorpion envenomation is, by definition, an environmentally/mechanically caused injury (ECTO/exposure framing: exposure to scorpion venom via sting). There are no separate "contributing" environmental toxins in the classic sense, though secondary environmental modifiers include: - Ambient temperature/season — scorpion activity and human outdoor/nocturnal exposure both increase in hot months, raising sting incidence. - Housing construction materials (thatch, mud-brick with crevices) enabling scorpion cohabitation with humans. - Rural/agricultural occupational exposure (see Etiology above).

Lifestyle factors: going barefoot, sleeping on the floor, not shaking out shoes/clothing before use, storing firewood/rubble near dwellings.

Infectious agents: not applicable — scorpion envenomation is not infectious, though secondary wound infection of necrotic cytotoxic lesions (e.g., from Hemiscorpius) can occur as a complication, not an etiologic agent.

Sources: Scorpionism at the human–environment interface – PMC13006650 · DHMOSH UN Guidance

6. Mechanism / Pathophysiology

Ordered causal chain

1. Venom injection via telson delivers a mixture of Na⁺-channel toxins (α-NaTx, β-NaTx), K⁺-channel toxins, phospholipases/hyaluronidase, and (in cytotoxic species) lytic enzymes into subcutaneous tissue → leads to local nociceptor activation (intense pain) and, for neurotoxic Buthidae venoms, rapid systemic absorption.
2. α-NaTx binds Nav channel VSD4 and blocks fast inactivation; β-NaTx binds Nav channel domain II voltage sensor and lowers the activation threshold → leads to prolonged Na⁺ influx and repetitive, uncontrolled action-potential firing at peripheral and autonomic nerve terminals (demonstrated structurally for AaH2-Nav complex, Science 2019).
3. Repetitive firing at sympathetic postganglionic terminals and the adrenal medulla → results in massive release of norepinephrine and epinephrine ("catecholamine storm") → tachycardia, hypertension, diaphoresis, hyperglycemia (via counter-regulatory hormone release), and increased myocardial oxygen demand.
4. Simultaneous repetitive firing at parasympathetic (cholinergic) terminals → results in acetylcholine release → bradycardia (in the later/mixed phase), hypersalivation, lacrimation, gastric hypermotility, priapism.
5. Catecholamine excess → leads to (a) direct catecholamine-induced myocardial injury ("adrenergic/toxic myocarditis," inflammatory infiltrate), and (b) increased myocardial O₂ demand with relative coronary hypoperfusion → myocardial ischemia — three convergent mechanisms proposed for cardiac dysfunction: adrenergic myocarditis, toxic (direct venom) myocarditis, and ischemia (PLOS NTD systematic review, PMID:37018229).
6. In parallel, venom (and the host inflammatory response to it) triggers IL-1 receptor signaling → induces prostaglandin E2 (PGE2) production → PGE2 drives excessive acetylcholine release at the heart via vagal efferents → causes acetylcholine-mediated cardiac dysfunction, heart failure, and death in a validated mouse model; IL-1R deficiency, dexamethasone, atropine, or vagotomy each abolish this pathway and prevent mortality (Nature Communications 2020, PMID/PMC7595177 — direct mechanistic/causal evidence, MODEL_ORGANISM).
7. A parallel IL-1R→nitric-oxide pathway in the pancreas has been shown to control hyperglycemia after envenomation (PMC7150851), linking the inflammatory cascade to the metabolic phenotype described in Section 3.
8. Direct toxin action plus catecholamine/cytokine-driven increases in pulmonary vascular permeability → leads to noncardiogenic-plus-cardiogenic pulmonary edema, the dominant proximate cause of death, sometimes with hemoptysis.
9. Combined cardiogenic (myocarditis/arrhythmia) and pulmonary (edema, hypoxia) failure → results in cardiogenic/cardiopulmonary shock, the terminal common pathway in fatal cases, typically within the first hours to ~24 hours after the sting.
10. Branch — cytotoxic (non-neurotoxic) venoms (e.g., Hemiscorpius lepturus): lysophospholipase D and other lytic enzymes directly lyse cell membranes at the sting site and systemically → leads to local dermonecrosis (initially painless) plus intravascular hemolysis, complement/coagulation activation, acquired ADAMTS13 deficiency (with autoantibody formation) → results in disseminated intravascular coagulation, thrombotic microangiopathy, and hemolytic-uremic syndrome with acute kidney injury — a mechanistically distinct downstream chain from the Nav/Kv-driven autonomic-storm pathway above.
11. Branch — pancreatic injury: autonomic hyperstimulation (direct cholinergic/adrenergic overactivity on acinar cells) plus possible direct venom enzymatic effects → leads to acute pancreatitis (elevated amylase/trypsinogen), contributing to abdominal pain/vomiting.
12. Branch — neurological: severe hypertensive surges and coagulopathy (in cytotoxic envenomation) can precipitate hemorrhagic or ischemic stroke; direct venom neuroexcitatory action can produce seizures independent of stroke.

Detail by mechanistic category

• Molecular pathways: Nav/Kv channel gating cascades (not classical signaling pathways like Wnt/MAPK); downstream, IL-1R→cyclooxygenase→PGE2→muscarinic acetylcholine signaling constitutes a defined, experimentally verified pathway (Nature Comm 2020).
• Cellular processes: exocytotic neurotransmitter release (GO:0007269 neurotransmission), sympathetic/parasympathetic neuron activation, cardiomyocyte injury/apoptosis-necrosis, inflammatory cytokine release, complement activation, erythrocyte lysis (cytotoxic venoms).
• Protein dysfunction: the "dysfunction" is imposed on host ion channels by toxin binding (gain-of-function-like persistent activation), not intrinsic host protein misfolding.
• Immune involvement: IL-1β/IL-1R–PGE2 axis is central and causally demonstrated; correlational human data link IL-1β and malondialdehyde (oxidative stress marker) to cardiac/pancreatic complication risk (PMC12670810).
• Tissue damage mechanisms: catecholamine-induced myocardial injury, hypoxic/ischemic injury from pulmonary edema, direct cytolysis (Hemiscorpius), oxidative stress (elevated MDA).
• Advanced/omics data: proteomic/transcriptomic venom-gland profiling (e.g., Tityus obscurus and T. serrulatus, PMID:29561852) has catalogued the toxin repertoire (Na/K channel toxins as the dominant "toxin core," alongside metalloproteinases and hyaluronidases) but there is no reported single-cell or spatial transcriptomic human host-response dataset specific to scorpion envenomation.

Suggested GO terms: GO:0086010 (membrane depolarization during action potential), GO:0001508 (action potential), GO:0007268 (chemical synaptic transmission), GO:0043473 (pigmentation — n/a), GO:0034405 (response to fluid shear stress — n/a), GO:0006954 (inflammatory response), GO:0019233 (sensory perception of pain), GO:0001516 (prostaglandin biosynthetic process), GO:0007613 (memory — n/a). Suggested CL terms: CL:0000101 (sensory neuron), CL:0011103 (sympathetic neuron), CL:0011105 (parasympathetic neuron), CL:0000746 (cardiac muscle cell), CL:0000232 (erythrocyte, for hemolytic branch), CL:0000583 (alveolar macrophage — inflammatory branch).

Sources: Interleukin-1 receptor-induced PGE2 production controls acetylcholine-mediated cardiac dysfunction and mortality – Nat Commun, PMC7595177 · IL-1R-induced NO production in the pancreas controls hyperglycemia – PMC7150851 · Scorpion envenomation-associated myocarditis: systematic review – PMID:37018229 / PLOS NTD · Cardiovascular dysfunction following severe scorpion envenomation: mechanisms – PMID:15687982 · Structural basis of α-scorpion toxin action on Nav channels – Science · Scorpion β-toxin interference with NaV channel voltage sensor – JGP · IL-1β/MDA correlation with cardiac and pancreatic complications – PMC12670810 · Proteomic/transcriptomic venom gland profiles – PMID:29561852 · High frequency of acquired ADAMTS13 deficiency – PMID:23893367

7. Anatomical Structures Affected

Organ level: - Primary: skin/subcutis (sting site), autonomic nervous system, heart, lungs. - Secondary: pancreas (pancreatitis), kidneys (AKI, especially cytotoxic species), brain (stroke, seizures — rare), eyes (periocular sting → corneal ulceration case report), genital vasculature (priapism). - Body systems: cardiovascular, respiratory, nervous (peripheral autonomic + central), endocrine/metabolic, hematologic (cytotoxic species), integumentary.

Tissue/cell level: peripheral sensory and autonomic (sympathetic and parasympathetic) neurons and nerve terminals; cardiomyocytes; pulmonary capillary endothelium (increased permeability); pancreatic acinar cells; renal tubular/glomerular endothelium (thrombotic microangiopathy in cytotoxic envenomation); erythrocytes (hemolysis).

Subcellular level: plasma-membrane voltage-gated Na⁺ and K⁺ channels (site of primary toxin action; GO Cellular Component: GO:0005248 voltage-gated sodium channel activity is a molecular function, GO:0034706 sodium channel complex is the CC term); synaptic vesicles (neurotransmitter exocytosis); mitochondria (secondary oxidative-stress injury).

Localization (UBERON): UBERON:0000948 (heart), UBERON:0002048 (lung), UBERON:0001264 (pancreas), UBERON:0002113 (kidney), UBERON:0001911 (skin of body — sting site, typically extremities), UBERON:0001021 (nerve), UBERON:0000375 (autonomic nerve — sympathetic/parasympathetic subdivisions).

Lateralization: local sting effects are unilateral/focal at the sting site; systemic effects are bilateral/generalized.

Sources: Cardiac involvement in scorpion envenomation: review · Corneal ulceration following periocular scorpion sting – PMC11199440 · Acute kidney injury and pancreatitis due to scorpion sting

8. Temporal Development

Onset: acute, occurring at any age but disproportionately in children; local pain is immediate, systemic/autonomic signs typically within 15 minutes to a few hours, cardiopulmonary complications typically within 1–24 hours.

Progression: most cases are self-limited over 24–48 hours (mild/moderate); severe envenomation can progress rapidly (hours) to cardiogenic shock, pulmonary edema, or death, particularly in young children with delayed treatment. There is no chronic/relapsing course analogous to a genetic disease, though rare chronic-relapsing pancreatitis has been reported as a late sequela in one case report from Trinidad (PMID:8687203).

Disease course pattern: acute, generally monophasic; biphasic autonomic pattern (early sympathetic surge, later parasympathetic/cholinergic phase) is well described clinically.

Critical period for intervention: the first several hours after the sting — antivenom is most effective when given early (systematic review/meta-analysis: antivenom reverses the clinical syndrome faster than no treatment; PMID:28390429), and IL-1R/PGE2 pathway blockade (dexamethasone) has been proposed for administration "very early after envenomation, even before antiserum" based on the mouse mechanistic model (PMC7595177).

Sources: Management of scorpion envenoming: systematic review and meta-analysis – PMID:28390429 · Chronic relapsing pancreatitis from scorpion sting – PMID:8687203 · Interleukin-1 receptor-induced PGE2 – PMC7595177

9. Inheritance and Population

Not a genetic/heritable disease — no inheritance pattern, penetrance, expressivity, anticipation, mosaicism, founder effect, or carrier frequency applies.

Epidemiology: - Global incidence: estimates range from ~1.2 million (Chippaux & Goyffon 2008, PMID:18579104) to ~1.5 million scorpion stings annually. - Global mortality: >3,000 deaths/year (Chippaux/Goyffon original estimate: >3,250 deaths, 0.27% case fatality across the seven at-risk regions); scorpion envenomation is described as the second leading cause of death from venomous animals after snakebite. - Regional burden: the MENA region accounts for ~42% of the global sting burden and roughly half of related mortality. High-burden countries: Mexico, Brazil, Iran, Algeria, Morocco, Tunisia, India. - Age distribution: children <15 years (especially <5–10 years) bear disproportionate morbidity/mortality. - Sex ratio: not sharply skewed in most series, though occupational exposure patterns can shift regional sex ratios (e.g., higher male exposure in agricultural work). - Geographic variant distribution: species-specific — Centruroides sculpturatus (Sonoran Desert bark scorpion) in the US Southwest/Mexico; Androctonus australis (North Africa, probably the most lethal species worldwide) and Leiurus quinquestriatus in North Africa/Middle East; Mesobuthus tamulus (Indian red scorpion) on the Indian subcontinent; Tityus serrulatus, T. bahiensis, T. obscurus, T. silvestris (Brazil/French Guiana/Amazon); Hemiscorpius lepturus (Iran, cytotoxic syndrome).

Sources: Epidemiology of scorpionism: a global appraisal – PMID:18579104 · Scorpionism: neglected tropical disease – PMC12170520 · Assessing the burden of Scorpionism in NW Iran – PMC12286322 · Epidemiological patterns in Ecuador – PMC11951006 · Distribution, biology, and management of medically relevant bark scorpions – Oxford J Integ Pest Mgmt

10. Diagnostics

Clinical diagnosis: history of sting/scorpion sighting plus characteristic local pain and, in moderate-severe cases, autonomic/neuromuscular signs; diagnosis is predominantly clinical, not laboratory-based, for triage.

Laboratory tests: - CBC (leukocytosis common), amylase/lipase (pancreatitis screening), glucose (hyperglycemia, prognostic), creatine kinase (rhabdomyolysis), renal function tests. - Cardiac biomarkers: troponin I shows limited discrimination between mild-moderate and severe groups in pediatric cohorts; NT-proBNP/proBNP is a more sensitive early predictor of pediatric cardiotoxicity, significantly elevated in severe cases at admission and at 12–24 hours (PMID:33994108; PMID:33094659). Emerging biomarkers sST2 and FABP-3 show association with LV dysfunction (sensitivity 92.3%) in a recent (2025) study ("New biomarkers in scorpion stings," PMID:39842516). - Coagulation studies, LDH, haptoglobin, ADAMTS13 activity, and Coombs testing for suspected Hemiscorpius-type hemolytic/DIC presentations.

Imaging: chest X-ray (pulmonary edema pattern), echocardiography (LV dysfunction, wall-motion abnormalities including takotsubo-like patterns; PMID:26135709 "Scorpion envenomation cardiomyopathy: a promising model for takotsubo syndrome"), cranial CT/MRI when stroke is suspected.

Electrophysiology: ECG for arrhythmia/ischemia surveillance (ST-T changes, QT prolongation reported); EEG if seizures.

Genetic testing: not applicable — no genetic test exists or is indicated for this condition.

Histopathology/biopsy: autopsy series document myocarditis (lymphocytic/catecholaminergic pattern), pulmonary edema, and occasionally pancreatic necrosis in fatal cases (PMC7551928, "Autopsy Findings in Case of Fatal Scorpion Sting: A Systematic Review").

Clinical severity/diagnostic criteria: several regionally validated classification systems (3-tier mild/moderate/severe; 4-grade systems incorporating local pain → systemic neuromuscular signs → cardiopulmonary collapse); a "Scorpion Envenomation: ICU Transfer Prediction Score" has recently been proposed (PMC13331192).

Differential diagnosis: other envenomations (spider bite, snakebite), acute abdomen/pancreatitis of other cause, myocardial infarction, sepsis, thyroid storm, pheochromocytoma crisis (given catecholamine excess phenotype), organophosphate poisoning (cholinergic overlap).

Screening: no population screening applicable; this is an acute injury, not a condition amenable to newborn/carrier screening.

Sources: The Role of ProBNP on Prognosis in Scorpion Stings – PMID:33994108 · NT-proBNP as early predictor of pediatric cardiotoxicity – PMID:33094659 · New biomarkers in scorpion stings – PMID:39842516 · Scorpion envenomation cardiomyopathy: a takotsubo model – PMID:26135709 · Autopsy findings in fatal scorpion sting – PMC7551928 · Scorpion Envenomation: ICU Transfer Prediction Score – PMC13331192 · Diagnostic value of GPX4, IL-13, periostin, thiol/disulfide balance – PMC12629928

11. Outcome/Prognosis

Mortality: overall case-fatality low (~0.27% globally per Chippaux/Goyffon), but far higher in untreated severe pediatric cases in endemic low-resource settings; confirmed myocarditis cases carry ~7.3% mortality. Pediatric ICU cohorts (e.g., Qena Governorate, Egypt) have specifically studied predictors of in-hospital mortality (PMC6779185).

Morbidity: most survivors recover fully within 24–72 hours; severe cases may have prolonged ICU stays (mechanical ventilation required in ~35% of severe respiratory-failure cases in one series) and, rarely, residual renal impairment (post-AKI, especially cytotoxic Hemiscorpius cases) or neurological deficits post-stroke.

Complications: cardiogenic shock, pulmonary edema, myocarditis/heart failure, acute pancreatitis, AKI/HUS (cytotoxic species), DIC, stroke (rare), priapism, secondary wound infection/necrosis.

Recovery potential: generally excellent with prompt supportive care ± antivenom; echocardiographic LV dysfunction (including takotsubo-pattern cardiomyopathy) is typically reversible over days to weeks.

Prognostic factors: young age (<5–10 years), delayed time-to-treatment (>3 hours), sting on torso/head/neck, elevated NT-proBNP/sST2/FABP-3, hyperglycemia at admission, species (e.g., Androctonus australis, Tityus serrulatus, Centruroides spp., Leiurus quinquestriatus associated with higher lethality than most other genera).

Sources: Scorpion envenomation-associated myocarditis: systematic review – PMID:37018229 · Predictors for Mortality in Children, Qena Governorate, Egypt – PMC6779185 · Predictive value of admission blood glucose – PMC12974955

12. Treatment

Pharmacotherapy — antivenom (specific antidote): - Species-specific F(ab′)₂ equine antivenom is first-line for moderate-severe envenomation by medically significant species. Systematic review/meta-analysis of controlled trials (PMID:28390429; PMC5385045) found antivenom against Centruroides effective in reversing the clinical syndrome faster than no antivenom (322 participants across 3 trials). - Anascorp® (Centruroides [Scorpion] Immune F(ab′)₂, equine) — FDA-approved August 4, 2011, the first US-approved scorpion antivenom (orphan drug, priority review). Pivotal RCT (Boyer et al., NEJM 2009, DOI:10.1056/NEJMoa0808455): 100% resolution of clinical syndrome within 4 hours vs. 14.3% with placebo in 15 pediatric ICU patients with clinically significant Centruroides envenomation. - Monovalent antivenom against Mesobuthus tamulus (India) combined with prazosin resolves symptoms faster than prazosin alone (mean difference ≈12.6 hours faster).

Adjunctive/symptomatic pharmacotherapy: - Prazosin (selective α1-adrenergic antagonist, CHEBI:8364) — counteracts catecholamine-mediated vasoconstriction/peripheral ischemia; established add-on for M. tamulus stings; NCIT: C15986 (Pharmacotherapy) as treatment action term, therapeutic_agent CHEBI:8364. - Dobutamine (β1-agonist inotrope) — for myocardial depression/cardiogenic shock, typical infusion 5–10 µg/kg/min (PMID:32428515, "Dobutamine in the treatment of severe scorpion envenoming"). - Atropine — for symptomatic bradycardia/excess cholinergic effects (mechanistically supported by the IL-1R/PGE2/acetylcholine pathway study, PMC7595177, where atropine or vagotomy abolished mortality in the mouse model). - Corticosteroids (dexamethasone) — proposed as very-early adjunct based on the same mechanistic model, to blunt IL-1R-driven PGE2/acetylcholine cascade; also explored in a 2024 review of "Immunosuppressive therapies in scorpion envenomation." - Levosimendan — case-report-level evidence for acute heart failure with renal impairment post-severe envenomation (PMC12360093). - Diuretics, nitroglycerin, digoxin — used adjunctively for pulmonary edema/heart failure management per clinical judgement. - Analgesics/local anesthetics — for local pain management in mild cases (most stings require only this).

Advanced therapeutics under development: - Nanobody (VHH, camelid single-domain antibody)-based antivenoms — smaller (15 kDa vs. ~100 kDa for F(ab′)₂), better tissue penetration; a camelid antibody candidate against Hemiscorpius lepturus venom has been described (PMC5395729), and recombinant scorpion-antivenom production in E. coli is an active area (2023 review, Appl Microbiol Biotechnol, DOI:10.1007/s00253-023-12578-1). - scFv/VHH recombinant fragments targeting Na⁺-channel neurotoxins are the focus of most recent pharmaceutical-development work, aiming to reduce serum-sickness risk associated with equine antivenoms.

Surgical/interventional: generally not indicated except for debridement/reconstruction of severe necrotic wounds from cytotoxic species (e.g., Hemiscorpius neck-defect reconstruction case report) or dialysis for AKI/HUS.

Supportive/critical care: cardiac monitoring, mechanical ventilation for respiratory failure (required in ~35% of severe cases in one cohort), ICU admission for grade III/IV envenomation, fluid/electrolyte management, glycemic monitoring.

Treatment algorithm: graded, severity-stratified — Grade I/mild: local care + analgesia; Grade II/moderate: antivenom ± prazosin, close monitoring; Grade III/IV/severe: antivenom + ICU-level supportive care (dobutamine, mechanical ventilation, atropine/steroids as adjuncts).

Experimental/clinical trials: NCT01599936 (Anascorp pediatric open-label trial), NCT01336660 (equine F(ab′)₂ trial, Morocco), NCT00753064 (AScVS and/or prazosin), NCT00696683 (natural history study), NCT00624078 (Anascorp treatment protocol).

Sources: Antivenom for Critically Ill Children with Neurotoxicity from Scorpion Stings – NEJM · Management of scorpion envenoming: systematic review/meta-analysis – PMID:28390429 · Dobutamine in the treatment of severe scorpion envenoming – PMID:32428515 · Emerging options for the management of scorpion stings – PMC3401053 · A camelid antibody candidate against Hemiscorpius lepturus – PMC5395729 · Production of recombinant scorpion antivenoms in E. coli – Appl Microbiol Biotechnol 2023 · Immunosuppressive therapies in scorpion envenomation – Frontiers Toxicol 2024 · Intravenous Levosimendan case report – PMC12360093 · FDA Anascorp label

13. Prevention

Primary prevention: - Footwear use outdoors/at night; shaking out shoes, clothing, and bedding before use. - Bed nets suspended beneath thatched or gapped roofing to prevent scorpions falling onto sleepers. - Sealing cracks/crevices in walls, floors, and foundations; removing woodpiles/rubble near dwellings; general household decluttering. - Community/occupational education campaigns for farmers, laborers, and rural residents (identified as most vulnerable groups).

Secondary prevention: rapid recognition and healthcare-seeking behavior; training of rural/peripheral healthcare workers in clinical recognition and immediate management, since time-to-treatment >3 hours independently predicts severity.

Tertiary prevention: ICU protocols to prevent/limit complications (mechanical ventilation readiness, cardiac monitoring, dialysis access for AKI) in endemic-region referral centers.

Immunization: no vaccine exists or is in development for scorpion envenomation (unlike some snake-antivenom vaccine research programs).

Screening/risk stratification: clinical severity-grading systems (Section 10) function as triage/risk-stratification tools rather than population screening.

Genetic counseling: not applicable.

Public health/environmental interventions: vector (scorpion) control around dwellings, improved housing construction standards, national/regional scorpion-sting surveillance and reporting systems (as increasingly implemented in Mexico, Iran, Ecuador).

Sources: Scorpionism at the human–environment interface – eco-epidemiological synthesis – PMC13006650 · DHMOSH UN Guidance for the Prevention and Management of Scorpion Stings · Scorpionism: neglected tropical disease with global public health implications – PMC12170520

14. Other Species / Natural Disease

Veterinary relevance: scorpion envenomation is a recognized cause of acute illness in domestic animals, especially dogs and cats in endemic regions. - A case report of a Tityus bahiensis sting in a small-breed dog documented pain, aggressiveness, tachypnea, tachycardia, and local erythema, resolving within 24 hours of supportive treatment (Brazil, ScienceDirect/SciELO case report). - A retrospective study of 11 dogs and 1 cat with scorpionism in Manizales, Colombia (2009–2018) found no fatalities; two severe and five moderate cases, with local pain and limb lameness as the primary presenting signs (PMID:31563524). - Death in animals, as in humans, occurs via cardiocirculatory failure and pulmonary edema. - Corneal ulceration following periocular scorpion sting has been reported (case report context; primarily human but illustrates ocular local-toxicity mechanism relevant across species) — PMC11199440.

Comparative biology: the Nav/Kv channel toxin mechanism is broadly conserved across mammals (and indeed across the arthropod prey targeted by these toxins in nature), which is why rodent (mouse, rat, guinea pig) and canine/feline models recapitulate core neuroexcitatory and cardiovascular phenotypes, though species-specific LD50 differences are substantial (e.g., toxicity of Buthus tamulus venom varies by age and species — LD50 in mice 7.2±1.35 vs. adult rats/guinea pigs 1.14±0.08, PMID:8146875).

Zoonotic potential: not applicable — scorpion envenomation is an injury, not a transmissible/zoonotic infectious disease.

Sources: Envenomation by scorpion in dog: case report · Retrospective study of scorpionism in 11 dogs and a cat, Colombia – PMID:31563524 · Toxicity of scorpion (Buthus tamulus) venom: age/species influence – PMID:8146875 · Merck Veterinary Manual: Spider and Scorpion Bites/Stings to Animals

15. Model Organisms

Rodent (mouse/rat) models are the dominant experimental system: - Mechanistic causal model: the IL-1R–PGE2–acetylcholine cardiac-dysfunction pathway was established in a mouse envenomation model, with genetic (IL-1R-knockout) and pharmacologic (dexamethasone, atropine, vagotomy) interventions each abolishing mortality — a high-fidelity, causally interrogable model of the human cardiotoxic phenotype (PMC7595177, Nat Commun 2020). - Hyperglycemia model: a parallel mouse model demonstrated an IL-1R–nitric oxide pancreatic pathway controlling venom-induced hyperglycemia (PMC7150851). - LD50/toxicity models: intraperitoneal or intracisternal venom injection in mice is the standard lethality assay across many species' venoms (e.g., Leiurus quinquestriatus IP LD50 ≈0.25–0.50 mg/kg; Hemiscorpius lepturus LD50 ≈177 µg/mouse); species- and age-dependent toxicity has been demonstrated across mice, rats, and guinea pigs (PMID:8146875). - Electrophysiology models: mouse phrenic nerve–hemidiaphragm and sciatic nerve preparations are used to study venom-induced neurotoxicity at the neuromuscular junction (e.g., Odontobuthus doriae venom studies, PMC3813362). - Cardiomyopathy model: rat/experimental models of scorpion-envenomation cardiomyopathy have been proposed as a naturally occurring analog of human takotsubo (stress) cardiomyopathy (PMID:26135709), offering a translational bridge for catecholamine-cardiotoxicity research generally. - Histopathology models: Hemiscorpius lepturus venom injected in mice reproduces the cytotoxic/hemolytic/nephrotoxic phenotype seen in human envenomation, supporting model validity for the cytotoxic-species branch of pathophysiology.

Model recapitulation vs. limitations: rodent models robustly recapitulate the acute autonomic/cardiotoxic and cytotoxic (Hemiscorpius) phenotypes and have been directly used to establish causal mechanism (not merely correlation) for the IL-1R/PGE2/acetylcholine pathway — an unusually strong (RECAPITULATES-grade) evidentiary link for a toxin-mediated syndrome. Limitations include species-dependent LD50/sensitivity differences (rodents vs. primates/humans) and the absence of validated large-animal or iPSC-cardiomyocyte models specific to this condition in the literature surveyed.

Model databases: no dedicated MGI/IMPC genetic-knockout resource exists for "scorpion envenomation" per se (it is an induced/pharmacologic model, not a genetic strain), but IL1R1-knockout mice (a standard IMPC/MGI-catalogued line) are the specific genetic tool used in the causal cardiotoxicity study above.

Sources: Interleukin-1 receptor-induced PGE2 production – PMC7595177 · IL-1R-induced NO production in the pancreas – PMC7150851 · Scorpion envenomation cardiomyopathy: takotsubo model – PMID:26135709 · Toxicity of scorpion venom influenced by age/species – PMID:8146875 · Effects of Odontobuthus doriae venom on mouse sciatic nerve – PMC3813362 · Histopathological changes induced by Hemiscorpius lepturus venom in mice

Reference Validation

Checked with linkml-reference-validator 0.2.1.

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

• HP:0001649 (1 mention) - the report calls it "Sympathetic predominance: tachycardia"; HP calls it Tachycardia
• HP:0001662 (1 mention) - the report calls it "Parasympathetic predominance: bradycardia"; HP calls it Bradycardia
• CL:0011105 (1 mention) - the report calls it "parasympathetic neuron"; CL calls it dopamanergic interplexiform cell
• UBERON:0001911 (1 mention) - the report calls it "skin of body — sting site, typically extremities"; UBERON calls it mammary gland

Obsolete terms

These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:

• HP:0031297 (obsolete Coronary sinus atrial septal defect) (1 mention) - replaced by HP:0011643

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

• MONDO:0018755 (1 mention) - the report calls it "scorpion envenomation; "has cause: scorpion sting"; MONDO calls it scorpion envenomation
• GO:0043473 (1 mention) - the report calls it "pigmentation — n/a"; GO calls it pigmentation
• GO:0034405 (1 mention) - the report calls it "response to fluid shear stress — n/a"; GO calls it response to fluid shear stress
• GO:0007613 (1 mention) - the report calls it "memory — n/a"; GO calls it memory
• CL:0000232 (1 mention) - the report calls it "erythrocyte, for hemolytic branch"; CL calls it erythrocyte
• CL:0000583 (1 mention) - the report calls it "alveolar macrophage — inflammatory branch"; CL calls it alveolar macrophage
• UBERON:0000375 (1 mention) - the report calls it "autonomic nerve — sympathetic/parasympathetic subdivisions"; UBERON calls it mandibular nerve, and lists "trigeminal nerve mandibular division" among its other names